Dashboard
Manage Tickers

PMNProMIS Neurosciences Inc.

Nasdaq promisneurosciences.com


$ 1.41 $ 0.03 (2.17 %)    

Tuesday, 17-Sep-2024 10:37:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 475.87 $ -0.10 (-0.02 %)
DIA $ 418.98 $ 0.99 (0.24 %)
SPY $ 565.53 $ 0.40 (0.07 %)
TLT $ 101.27 $ -0.06 (-0.06 %)
GLD $ 237.65 $ -0.33 (-0.14 %)
$ 1.38
$ 1.40
$ 1.33 x 100
$ 1.43 x 137
$ 1.40 - $ 1.41
$ 0.95 - $ 3.10
131,479
na
41.24M
$ 17.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

promis-neurosciences-inc-files-for-resale-from-time-to-time-of-565m-common-shares-of-co-by-selling-stockholders
ProMIS Neurosciences Inc Files For Resale ...
08/29/2024 20:39:24

promis-neurosciences-granted-us-patent-12071472-for-methods-of-reducing-toxicity-induced-by-amyloid-beta-oligomers-using-antibodies-specific-to-a-beta-oligomers-in-alzheimers-treatment
ProMIS Neurosciences Granted US Patent 12,...
08/27/2024 18:01:59

around-2m-bet-on-this-health-care-stock-check-out-these-3-stocks-under-5-insiders-are-aggressively-buying
Around $2M Bet On This Health Care Stock? ...
08/19/2024 11:48:51

why-ainos-shares-are-trading-higher-by-around-38-here-are-20-stocks-moving-premarket
Why Ainos Shares Are Trading Higher By Aro...
08/12/2024 10:04:36

promis-neurosciences-q2-2024-gaap-eps-013-beats-014-estimate
ProMIS Neurosciences Q2 2024 GAAP EPS $(0....
08/08/2024 12:20:20

promis-neurosciences-reveals-data-on-the-pathogenic-role-of-toxic-misfolded-sod1-aggregates-in-als
ProMIS Neurosciences Reveals Data On The P...
08/06/2024 11:07:20

Body of work supports targeting misfolded proteins as a therapeutic strategy for ALS with the potential to translate across mul...

promis-neurosciences-presents-preclinical-data-supporting-alzheimers-vaccine-approach-shows-strong-antibody-responses-with-no-pro-inflammatory-t-cell-responses-against-ao-at-aaic-2024
ProMIS Neurosciences Presents Preclinical ...
07/30/2024 12:37:19

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

promis-neurosciences-reports-top-line-data-from-the-first-four-cohorts-of-its-first-in-human-phase-1a-clinical-trial-of-pmn310-in-healthy-volunteers-for-alzheimers-disease-patients-topline-results-demonstrated-a-favorable-safety-profile-and-tolerability-across-four-ascending-dose-levels
ProMIS Neurosciences Reports Top-Line Data...
07/26/2024 12:38:48

Topline results demonstrated a favorable safety profile and tolerability across four ascending dose levels in healthy volunteer...

promis-neurosciences-announces-up-to-1227m-private-placement-financing-proceeds-expected-to-support-company-beyond-6-month-and-12-month-data-from-the-pmn310-phase-ib-study-in-alzheimers-patients
ProMIS Neurosciences Announces Up To $122....
07/26/2024 12:34:30

$30.3 million financing upfront with up to an additional $92.4 million tied to exercise of warrants, with certain of the warran...

promis-neurosciences-q1-2024-adj-eps-019-beats-020-estimate
ProMIS Neurosciences Q1 2024 Adj EPS $(0.1...
05/14/2024 20:21:44

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $...

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings
Dow Jumps Over 300 Points; Goldman Sachs P...
04/15/2024 14:00:00

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...

promis-neurosciences-q4-eps-009-beats-017-estimate
ProMIS Neurosciences Q4 EPS $(0.09) Beats ...
04/02/2024 12:09:02

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $...

promis-neurosciences-reveals-strengthening-of-global-intellectual-property-portfolio
ProMIS Neurosciences Reveals Strengthening...
03/11/2024 11:19:42

The European Patent Office, Japanese Patent Office and IP Australia, the Australian patent office, have recently allowed compos...

promis-neurosciences-has-selected-the-lead-vaccine-candidate-pmn400-against-multiple-synucleinopathies-including-multiple-system-atrophy-parkinsons-disease-and-lewy-body-dementia
ProMIS Neurosciences Has Selected The Lead...
01/22/2024 12:35:03

why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session
Why TransCode Therapeutics Shares Are Trad...
01/19/2024 18:05:18

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

promis-neurosciences-appoints-neil-warma-as-interim-chief-executive-officer
ProMIS Neurosciences Appoints Neil Warma A...
01/03/2024 12:17:43

promis-neurosciences-q3-eps-019-up-from-085-yoy
ProMIS Neurosciences Q3 EPS $(0.19) Up Fro...
11/14/2023 22:38:43

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.19) per share. This is a 77.65 percent increase over losses ...

benzingas-top-ratings-upgrades-downgrades-for-october-3-2023
Benzinga's Top Ratings Upgrades, Downgrade...
10/03/2023 15:00:54

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION